These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation. Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032 [TBL] [Abstract][Full Text] [Related]
12. Everolimus in lung transplantation in Chile. Parada MT; Alba A; Sepúlveda C Transplant Proc; 2010; 42(1):328-30. PubMed ID: 20172343 [TBL] [Abstract][Full Text] [Related]
13. Replacing calcineurin inhibitors with mTOR inhibitors in children. Sindhi R; Seward J; Mazariegos G; Soltys K; Seward L; Smith A; Kosmach B; Venkataramanan R Pediatr Transplant; 2005 Jun; 9(3):391-7. PubMed ID: 15910398 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
15. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140 [TBL] [Abstract][Full Text] [Related]
16. Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity. Chang HR; Lee MH; Wen MC; Lian JD Transplant Proc; 2004 Nov; 36(9):2668-70. PubMed ID: 15621119 [TBL] [Abstract][Full Text] [Related]
17. Early sirolimus therapy in renal transplant recipients at high risk: is it justified? Halim MA; Al-Otaibi T; Johny KV; Hamid MH; Al-Waheeb S; Hasaneen H; Awadain WH; Nawas KM; El-Sayed A; Said T; Nair MP; Nampoory MR Transplant Proc; 2009 Sep; 41(7):2784-8. PubMed ID: 19765435 [TBL] [Abstract][Full Text] [Related]
18. High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation. Gelens MA; Christiaans MH; van Heurn EL; van den Berg-Loonen EP; Peutz-Kootstra CJ; van Hooff JP Transplantation; 2006 Nov; 82(9):1221-3. PubMed ID: 17102775 [TBL] [Abstract][Full Text] [Related]
19. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Forgacs B; Merhav HJ; Lappin J; Mieles L Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502 [TBL] [Abstract][Full Text] [Related]
20. Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis. Ohara T; Oto T; Miyoshi K; Tao H; Yamane M; Toyooka S; Okazaki M; Date H; Sano Y Ann Thorac Surg; 2008 Dec; 86(6):e7-8. PubMed ID: 19021963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]